Summary
This prediction ended on 09.11.16 with a price of €91.18. The BUY prediction by Quitte finished with a performance of 3.17%. Quitte has 50% into this predictionBayer is a multinational pharmaceutical and life sciences company headquartered in Germany. The company was founded in 1863 and has since grown to become a global leader in the fields of pharmaceuticals, agriculture, and consumer health. Bayer is listed on the Frankfurt Stock Exchange and also trades over-the-counter in the United States under the ticker symbol BAYZF. The company's products include prescription drugs, over-the-counter medicines, and agrochemicals, and it operates in more than 90 countries around the world.
AI-generated
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Bayer AG | 0.499% | 0.499% | 73.138% | -4.182% |
| iShares Core DAX® | -1.586% | 5.028% | 6.332% | 64.061% |
| iShares Nasdaq 100 | -4.148% | -0.125% | 25.735% | 86.918% |
| iShares Nikkei 225® | -6.302% | 0.528% | 41.384% | 77.872% |
| iShares S&P 500 | -3.225% | 0.470% | 20.449% | 68.192% |
Comments by Quitte for this prediction
In the thread Bayer AG diskutieren
allgemeine Erholung zur US-Wahl
und eine kleine Nachricht
IN KÜRZE-Bayer beantragt Zulassung für Regorafenib bei Leberkrebs
Mehr über die Bayer Aktie erfahren.